From: Epidemiology of hepatitis B, C and D in Malawi: systematic review
Population | Ref | Year | Location | Method | Prevalence (n/total) | Prevalence (%, (95% CI)) |
---|---|---|---|---|---|---|
Prisoners | [28] | 2007 | Chichiri Prison, Blantyre | Anti-HCV (Biotec) | 0/164 | 0.0 (0.0, 2.3) |
Adult inpatients (Dermatology, Urology) | [32] | 1996 | KCH, Lilongwe | Anti-HCV EIA (Roche) Confirmed with Anti-HCV (Abbott) | 13/333 | 3.9 (2.3, 6.6) |
Adult medical inpatients | [27] | 2004 | Medical ward, QECH, Blantyre | HCV Ag/Ab (Monolisa, Biorad) confirmed with Immunoassay (Innogenetics) | 9/202 | 4.5 (2.4, 8.2) |
Malawian women and children with childhood malignancies | [34] | 2006–10 | QECH, Blantyre | HBV ELISA (MP Biomedicals) | Mothers: 2/418 | 0.5 (0.1, 1.7) |
Confirmed by HCV BLOT (MP Biomedicals) | Children: 1/418 | 0.2 (0.0, 1.3) |